Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News

Related Searches: Industry News •
Mylan to Acquire Bioniche Injectable Business

July 15, 2010
Mylan, Inc. has plans to acquire Bioniche Pharma Holdings Ltd., a global injectable pharmaceutical company, for $550 million in cash.   Read More »
PPD

July 15, 2010
Henrietta Ukwu, M.D., FACP, FRAPS, has been appointed senior vice president of global regulatory affairs, PPD, Inc.   Read More »
Pfizer, SMC Enter Liver Cancer Research Pact

July 14, 2010
Pfizer and Samsung Medical Center (SMC) have formed a research partnership to jointly analyze tumors from Korean patients to generate gene expression profiles in an effort to direct therapies and enhance clinical outcomes in the patients with liver cancer  Read More »
ICON

July 14, 2010
Jonathan M Fishbein, M.D. has been appointed vice president and Global Head for the Infectious Disease & Vaccines Therapeutic Group at ICON Clinical Research.  Read More »
Aestus, Eisai Enter Psychiatric Drug Pact

July 14, 2010
Aestus Therapeutics and Eisai have entered into a collaboration to research and develop therapeutics for the treatment of psychiatric disorders.   Read More »
HGS, Lonza Enter Benlysta Manufacturing Pact

July 13, 2010
Human Genome Sciences, Inc. and Lonza entered an agreement for the commercial supply of Benlysta (belimumab), which is currently under regulatory review in the U.S. and EU as a potential treatment for systemic lupus erythematosus (SLE).  Read More »
RCUK Selects IDT as Preferred Oligo Supplier

July 13, 2010
Integrated DNA Technologies (IDT) has signed a three-year contract with Research Councils UK (RCUK) for the supply of synthetic oligonucleotides.  Read More »
OctoPlus, The Medicines Co. Sign Development Contract

July 13, 2010
OctoPlus N.V. has signed a development and manufacturing contract with U.S.-based The Medicines Company.   Read More »
Clinuvel Gets Positive Phase III Scenesse Results

July 13, 2010
Clinuvel Pharmaceuticals achieved positive results from a Phase III trial of Scenesse in patients with erythropoietic protoporphyria (EPP), showing that the drug has the ability to reduce and prevent painful phototoxic reactions.  Read More »
Xcelience, Penn Pharma Form API JV

July 12, 2010
Penn Pharma and Xcelience, LLC have entered into a joint venture agreement to provide Capsugel’s Xcelodose precision powder micro-dosing system technology on a global basis.  Read More »
BioStorage Technologies

July 12, 2010
Lisa Gilbert has been appointed global director of marketing at BioStorage Technologies Inc.   Read More »
GVK Biosciences Earns AAALAC Accreditation

July 12, 2010
GVK Biosciences has received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International for its animal facilities.  Read More »
MRC Technology, Genentech Enter Drug Pact

July 12, 2010
MRC Technology has entered into an agreement with Genentech, a wholly owned member of the Roche Group, for an exclusive license to a series of small molecule drug candidates for the potential treatment of neurological disease.  Read More »
ISC&P

July 12, 2010
John Cox has been named executive vice president, International Specialty Chemicals & Pharmaceuticals (ISC&P).   Read More »
Almac

July 9, 2010
Bill Kane has joined Almac’s Clinical Technologies division as director of Quality Assurance and Regulatory Compliance.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: